BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32430974)

  • 1. Good things come to those who wait: Successful response of solar urticaria to omalizumab after 1 year of treatment.
    Vollono L; Bianchi L; Piccolo A; Mazzilli S; Campione E; Diluvio L
    Photodermatol Photoimmunol Photomed; 2020 Sep; 36(5):408-411. PubMed ID: 32430974
    [No Abstract]   [Full Text] [Related]  

  • 2. Incapacitating solar urticaria: successful treatment with omalizumab.
    Kieselova K; Santiago F; Henrique M
    An Bras Dermatol; 2019 Jul; 94(3):331-333. PubMed ID: 31365663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solar urticaria induced by visible light: successful treatment with omalizumab.
    Terrani I; Bircher AJ; Scherer Hofmeier K
    Clin Exp Dermatol; 2016 Dec; 41(8):890-892. PubMed ID: 27766671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solar urticaria caused by visible light in a 33-year-old male refractory to treatment with omalizumab.
    Wright E; Kurland E; Lim HW
    Photodermatol Photoimmunol Photomed; 2020 Jul; 36(4):316-317. PubMed ID: 32141097
    [No Abstract]   [Full Text] [Related]  

  • 5. Partial improvement of solar urticaria after omalizumab.
    Waibel KH; Reese DA; Hamilton RG; Devillez RL
    J Allergy Clin Immunol; 2010 Feb; 125(2):490-1. PubMed ID: 20159260
    [No Abstract]   [Full Text] [Related]  

  • 6. Real-life experience in the treatment of solar urticaria: retrospective cohort study.
    Snast I; Lapidoth M; Uvaidov V; Enk CD; Mazor S; Hodak E; Levi A
    Clin Exp Dermatol; 2019 Jul; 44(5):e164-e170. PubMed ID: 30828851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to Omalizumab in Solar Urticaria: Report of 3 Cases.
    Rodríguez-Jiménez P; Chicharro P; Pérez-Plaza A; de Argila D
    Actas Dermosifiliogr; 2017 Oct; 108(8):e53-e55. PubMed ID: 28457471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful omalizumab treatment of severe solar urticaria in a 6-year-old child.
    Levi A; Tal Y; Dranitzki Z; Shalit M; Enk CD
    Pediatr Allergy Immunol; 2015 Sep; 26(6):588-90. PubMed ID: 26172942
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment with omalizumab in a 16-year-old Caucasian girl with refractory solar urticaria.
    Arasi S; Crisafulli G; Caminiti L; Guarneri F; Aversa T; Porcaro F; Pajno GB
    Pediatr Allergy Immunol; 2015 Sep; 26(6):583-5. PubMed ID: 26033828
    [No Abstract]   [Full Text] [Related]  

  • 10. Solar urticaria treated with omalizumab.
    Schaffenburg WC; Guerrero KT; Marks SN
    Cutis; 2019 Jul; 104(1):E4-E5. PubMed ID: 31487346
    [No Abstract]   [Full Text] [Related]  

  • 11. [Partial response of solar urticaria to omalizumab therapy].
    Kowalzick L; Thiel W; C Bielfeld ; Ziegler H; Eickenscheidt L
    Hautarzt; 2017 Jun; 68(6):492-496. PubMed ID: 27995273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of omalizumab in severe solar urticaria.
    de Dios-Velázquez Á; González-de Arriba M; Beteta-Gorriti V; Macías E; Campanón-Toro V; Dávila I
    Ann Allergy Asthma Immunol; 2016 Mar; 116(3):260-2. PubMed ID: 26803538
    [No Abstract]   [Full Text] [Related]  

  • 13. Refractory solar urticaria successfully treated with omalizumab with normalization of phototest.
    Combalia A; Fernández-Sartorio C; Aguilera P
    Actas Dermosifiliogr; 2017; 108(6):593-594. PubMed ID: 28168968
    [No Abstract]   [Full Text] [Related]  

  • 14. Long term treatment with omalizumab in adolescent with refractory solar urticaria.
    Iannelli M; Passanisi S; Crisafulli G; Arasi S; Caminiti L; Zirilli G; Pajno GB
    Ital J Pediatr; 2021 Sep; 47(1):195. PubMed ID: 34583772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of refractory cholinergic urticaria with omalizumab.
    Koumaki D; Seaton ED
    Int J Dermatol; 2018 Jan; 57(1):114. PubMed ID: 29057464
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful treatment of occupational delayed pressure urticaria and angioedema with omalizumab.
    Geller M
    Ann Allergy Asthma Immunol; 2016 Jan; 116(1):81-2. PubMed ID: 26602491
    [No Abstract]   [Full Text] [Related]  

  • 17. Omalizumab as Third-Line Therapy for Urticaria During Pregnancy.
    Ensina LF; Cusato-Ensina AP; Camelo-Nunes IC; Solé D
    J Investig Allergol Clin Immunol; 2017; 27(5):326-327. PubMed ID: 29057743
    [No Abstract]   [Full Text] [Related]  

  • 18. Omalizumab in An 8-Year-Old Boy With Diabetes Mellitus and Refractory Chronic Spontaneous Urticaria.
    Jesenak M; Ciljakova M; Janickova M; Banovcin P
    J Investig Allergol Clin Immunol; 2019 Apr; 29(2):144-146. PubMed ID: 31017115
    [No Abstract]   [Full Text] [Related]  

  • 19. Omalizumab for chronic spontaneous urticaria: a boon for sufferers, but there are unanswered questions.
    Greaves MW
    Br J Dermatol; 2015 Aug; 173(2):321. PubMed ID: 26346076
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic spontaneous urticaria in an 8-year-old girl treated with omalizumab.
    Ossorio-García L; Jiménez-Gallo D; Albarrán-Planelles C; Arjona-Aguilera C; Linares-Barrios M
    Clin Exp Dermatol; 2016 Dec; 41(8):929-930. PubMed ID: 27761937
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.